Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

BACKGROUND: Validated biomarkers to evaluate HIV-1 cure strategies are currently lacking, therefore requiring analytical treatment interruption (ATI) in study participants. Little is known about the safety of ATI and its long-term impact on patient health. OBJECTIVES: ATI safety was assessed and pot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: De Scheerder, Marie-Angélique, Van Hecke, Clarissa, Zetterberg, Henrik, Fuchs, Dietmar, De Langhe, Nele, Rutsaert, Sofie, Vrancken, Bram, Trypsteen, Wim, Noppe, Ytse, Van Der Gucht, Bea, Pelgrom, Jolanda, Van Wanzeele, Filip, Palmer, Sarah, Lemey, Philippe, Gisslén, Magnus, Vandekerckhove, Linos
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869780/
https://ncbi.nlm.nih.gov/pubmed/32053203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados